Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
960.00    24.00 (2.56%)
Bid:
924.00
Ask:
944.00
Spread: 20.00 (2.165%)
Market Cap: £262.76m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Full-Year Trading Update

4 Oct 2011 07:00

RNS Number : 4702P
Gooch & Housego PLC
04 October 2011
 



 

For immediate release

4 October 2011

 

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Full-Year Trading Update

 

Gooch & Housego PLC, the specialist manufacturer of optical components & systems, today announces that results for the year ended 30 September 2011will be in line with market expectations. Preliminary results will be announced on 29 November 2011.

 

Favourable market conditions prevailed for the first three quarters of the year and strong demand was experienced across most market and product sectors. The acquisitions of EM4 and Crystal Technology during the second quarter contributed to revenue and profit growth and accelerated the diversification of the business. G&H's presence in the aerospace & defence, life sciences and telecommunications markets has been significantly enhanced, while the Company's market leadership in acousto-optics and electro-optics for industrial applications has also been reinforced. Given the fragile global economic environment we did anticipate some softening in demand in the final quarter, although this has been confined to certain product sectors and geographical markets. Greater diversification and growth in new markets has mitigated some of the effects of the slowing demand in other sectors.

 

The integration of the new acquisitions is progressing well. The rationale for G&H's acquisition of EM4 was demonstrated by a number of significant contract wins for strategic defence programs including the recent award of a $3+ million contract by a large US defence contractor for the first phase of the design, development and supply of fibre optic systems. Plans to duplicate G&H Torquay's passive fibre optics technology at EM4's Boston site, in order to access the large US aerospace & defence market for these products, are already well-advanced with the first products expected to be available for qualification testing in early 2012.

 

Crystal Technology has performed strongly during the first six months of G&H ownership, with revenues from all major markets exceeding original plan. The transfer of crystal growing from the Crystal Technology facility in Palo Alto to G&H's Cleveland operation - a major undertaking requiring the fitting out of a new 30,000 square foot facility - is making good progress. The facility is essentially complete and the first crystals have been grown. It is expected that production will be fully transferred by the end of the calendar year.

 

Gareth Jones, Chief Executive of Gooch & Housego commented: -

 

"During the past twelve months we have made progress towards achieving the key strategic and commercial objectives of greater diversification and strong organic and acquisitive growth. The uncertain economic climate will present challenges in the coming year but Gooch & Housego is well-positioned to deliver the next phase of its strategy as we seek to leverage the exceptional products, technologies and capabilities that the company now has to offer."

 

For further information please contact:

 

Gareth Jones/Andrew Boteler, 01460 256440

Tim Thompson/Nicola Cronk, Buchanan, 020 7466 5000

Patrick Robb/James Grace, Investec Bank plc, 020 7597 5970

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFSDFMDFFSEDS
Date   Source Headline
3rd Dec 20137:00 amRNSPreliminary Results
26th Nov 20137:00 amRNSAcquisition of Constelex Technology Enablers Ltd
1st Nov 20137:00 amRNSNotification of Preliminary Results
29th Oct 201312:06 pmRNSHolding(s) in Company
15th Oct 201310:17 amRNSHolding(s) in Company
15th Oct 20137:00 amRNSAcquisition of Spanoptic Limited
8th Oct 201311:21 amRNSHolding(s) in Company
7th Oct 20137:00 amRNSFull-Year Trading Update
1st Oct 201311:52 amRNSHolding(s) in Company
18th Sep 20137:00 amRNSCapital Markets Day
9th Sep 20132:38 pmRNSHolding(s) in Company
25th Jul 20135:54 pmRNSHolding(s) in Company
25th Jul 20135:52 pmRNSHolding(s) in Company
12th Jul 20133:12 pmRNSDirector/PDMR Shareholding
12th Jul 20133:11 pmRNSDirector/PDMR Shareholding
12th Jul 20133:09 pmRNSDirector/PDMR Shareholding
12th Jul 20133:07 pmRNSDirector/PDMR Shareholding
12th Jul 20133:05 pmRNSDirector/PDMR Shareholding
11th Jun 20137:00 amRNSSales and Marketing drive
11th Jun 20137:00 amRNSInterim Report
9th May 20137:00 amRNSNotification of Interim Results
10th Apr 20137:00 amRNSNew Long Term Incentive Plan and grant of Awards
8th Apr 20137:00 amRNSHalf Year Trading Update
19th Mar 201310:44 amRNSAnnual Report and Accounts
15th Mar 201310:50 amRNSHolding(s) in Company
1st Mar 20134:09 pmRNSDirector/PDMR Shareholding
1st Mar 20134:05 pmRNSDirector/PDMR Shareholding
1st Mar 20134:03 pmRNSDirector/PDMR Shareholding
1st Mar 20134:01 pmRNSDirector/PDMR Shareholding
28th Feb 20137:00 amRNSResults of Annual General Meeting
27th Feb 201311:24 amRNSAIM Disclosure Update
27th Feb 20137:00 amRNSTrading Update
4th Feb 20133:00 pmRNSAdditional Listing
18th Jan 20132:12 pmRNSDirector/PDMR Shareholding
18th Jan 20132:11 pmRNSDirector/PDMR Shareholding
18th Jan 20132:09 pmRNSDirector/PDMR Shareholding
10th Jan 20133:00 pmRNSAdditional Listing
7th Jan 20137:00 amRNSValue Creation Plan Crystallises
13th Dec 20124:43 pmRNSHolding(s) in Company
27th Nov 20127:00 amRNSPreliminary Results
23rd Oct 20129:34 amRNSHolding(s) in Company
15th Oct 201211:02 amRNSHolding(s) in Company
5th Oct 20127:00 amRNSDirector change
4th Oct 20127:00 amRNSFull-Year Trading Update
25th Sep 20129:53 amRNSHolding(s) in Company
24th Sep 20122:09 pmRNSAdditional Listing
19th Sep 20128:47 amRNSAdditional Listing
19th Sep 20128:45 amRNSDirector/PDMR Shareholding
4th Sep 20122:14 pmRNSHolding(s) in Company
4th Sep 201210:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.